Mitra Korani

708 total citations
19 papers, 523 citations indexed

About

Mitra Korani is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Mitra Korani has authored 19 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Hematology. Recurrent topics in Mitra Korani's work include Multiple Myeloma Research and Treatments (5 papers), Nanoparticles: synthesis and applications (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Mitra Korani is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Nanoparticles: synthesis and applications (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). Mitra Korani collaborates with scholars based in Iran, United States and United Kingdom. Mitra Korani's co-authors include Shahla Korani, Amirhossein Sahebkar, M Rezayat, Kambiz Gilani, Sepideh Arbabi Bidgoli, Seyed Mahdi Rezayat, Afshin Mohammadi‐Bardbori, Zahra Hami, Thomas P. Johnston and Thozhukat Sathyapalan and has published in prestigious journals such as Journal of Cellular Physiology, Drug Discovery Today and Journal of Cellular Biochemistry.

In The Last Decade

Mitra Korani

19 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitra Korani Iran 12 209 122 80 77 76 19 523
Aneta Węgierek-Ciuk Poland 11 223 1.1× 146 1.2× 122 1.5× 73 0.9× 70 0.9× 25 718
Nilesh Kanase United Kingdom 9 235 1.1× 101 0.8× 128 1.6× 49 0.6× 32 0.4× 9 527
Shiow‐Yi Chen Taiwan 12 232 1.1× 236 1.9× 169 2.1× 49 0.6× 77 1.0× 26 773
Carlos Medina Ireland 12 133 0.6× 104 0.9× 119 1.5× 120 1.6× 46 0.6× 16 531
Jingxian Wang China 17 87 0.4× 142 1.2× 47 0.6× 32 0.4× 50 0.7× 59 787
Usha Singh Gaharwar India 9 159 0.8× 124 1.0× 90 1.1× 95 1.2× 15 0.2× 15 553
Hongjie Ruan China 14 95 0.5× 297 2.4× 153 1.9× 174 2.3× 52 0.7× 31 788
Zhongjie Yu China 9 290 1.4× 181 1.5× 184 2.3× 89 1.2× 31 0.4× 19 695
Asaad Azarnezhad Iran 15 215 1.0× 184 1.5× 185 2.3× 91 1.2× 34 0.4× 39 767

Countries citing papers authored by Mitra Korani

Since Specialization
Citations

This map shows the geographic impact of Mitra Korani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitra Korani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitra Korani more than expected).

Fields of papers citing papers by Mitra Korani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitra Korani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitra Korani. The network helps show where Mitra Korani may publish in the future.

Co-authorship network of co-authors of Mitra Korani

This figure shows the co-authorship network connecting the top 25 collaborators of Mitra Korani. A scholar is included among the top collaborators of Mitra Korani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitra Korani. Mitra Korani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Korani, Shahla, et al.. (2024). Applications of honeybee-derived products in bone tissue engineering. Bone Reports. 20. 101740–101740. 2 indexed citations
2.
Rashidi, Khodabakhsh, Mitra Korani, Houshang Nemati, et al.. (2023). The Combined Effect of Curcumin and Crocin on the Reduction ofInflammatory Responses in Arthritic Rats. Current Medicinal Chemistry. 31(28). 4562–4577. 3 indexed citations
3.
Mohammadi, Ghobad, Mitra Korani, Houshang Nemati, et al.. (2022). Crocin-loaded nanoliposomes: Preparation, characterization, and evaluation of anti-inflammatory effects in an experimental model of adjuvant-induced arthritis. Journal of Drug Delivery Science and Technology. 74. 103618–103618. 10 indexed citations
4.
Korani, Shahla, et al.. (2021). Bortezomib: a proteasome inhibitor for the treatment of autoimmune diseases. Inflammopharmacology. 29(5). 1291–1306. 28 indexed citations
5.
Korani, Mitra, Shahla Korani, Elham Delzendeh, et al.. (2020). Utilization of Lipid-based Nanoparticles to Improve the Therapeutic Benefits of Bortezomib. Anti-Cancer Agents in Medicinal Chemistry. 20(6). 643–650. 8 indexed citations
6.
Korani, Mitra, Sara Nikoofal‐Sahlabadi, Amin Reza Nikpoor, et al.. (2020). The Effect of Phase Transition Temperature on Therapeutic Efficacy of Liposomal Bortezomib. Anti-Cancer Agents in Medicinal Chemistry. 20(6). 700–708. 15 indexed citations
7.
Korani, Mitra, Solmaz Ghaffari, Hossein Attar, Mohammad Mashreghi, & Mahmoud Reza Jaafari. (2019). Preparation and characterization of nanoliposomal bortezomib formulations and evaluation of their anti-cancer efficacy in mice bearing C26 colon carcinoma and B16F0 melanoma. Nanomedicine Nanotechnology Biology and Medicine. 20. 102013–102013. 33 indexed citations
8.
Korani, Shahla, et al.. (2019). Parenteral systems for statin delivery: a review. Lipids in Health and Disease. 18(1). 193–193. 28 indexed citations
9.
Korani, Mitra, Shahla Korani, Elham Delzendeh, et al.. (2019). Enhancing the Therapeutic Efficacy of Bortezomib in Cancer Therapy Using Polymeric Nanostructures. Current Pharmaceutical Design. 25(46). 4883–4892. 7 indexed citations
10.
Korani, Shahla, Mitra Korani, Thozhukat Sathyapalan, & Amirhossein Sahebkar. (2019). Therapeutic effects of Crocin in autoimmune diseases: A review. BioFactors. 45(6). 835–843. 58 indexed citations
11.
Korani, Shahla, Mitra Korani, Thomas P. Johnston, et al.. (2018). Application of nanotechnology to improve the therapeutic benefits of statins. Drug Discovery Today. 24(2). 567–574. 37 indexed citations
12.
Delzendeh, Elham, Elham Abdollahi, Amir Abbas Momtazi‐Borojeni, et al.. (2018). The molecular mechanisms of curcumin’s inhibitory effects on cancer stem cells. Journal of Cellular Biochemistry. 120(4). 4739–4747. 26 indexed citations
13.
Korani, Shahla, Mitra Korani, Alexandra E. Butler, & Amirhossein Sahebkar. (2018). Genetics and rheumatoid arthritis susceptibility in Iran. Journal of Cellular Physiology. 234(5). 5578–5587. 11 indexed citations
14.
Korani, Mitra, et al.. (2015). Effects of silver nanoparticles on human health. 7(1). 51–62. 87 indexed citations
15.
Korani, Mitra, Seyed Mahdi Rezayat, & Sepideh Arbabi Bidgoli. (2013). Sub-chronic Dermal Toxicity of Silver Nanoparticles in Guinea Pig: Special Emphasis to Heart, Bone and Kidney Toxicities.. PubMed. 12(3). 511–9. 60 indexed citations
16.
Bidgoli, Sepideh Arbabi, et al.. (2013). Toxicity assessment of nanosilver wound dressing in Wistar rat.. PubMed. 51(4). 203–8. 23 indexed citations
17.
Bidgoli, Sepideh Arbabi, et al.. (2011). Association between glycodelin and aryl hydrocarbon receptor in Iranian breast cancer patients: impact of environmental endocrine disrupting chemicals.. PubMed. 12(9). 2431–5. 3 indexed citations
18.
Korani, Mitra, M Rezayat, & Kambiz Gilani. (2011). Acute and subchronic dermal toxicity of nanosilver in guinea pig. International Journal of Nanomedicine. 6. 855–855. 83 indexed citations
19.
Simpson, L.O., et al.. (2003). Study of erythrocyte shape changes in schistosomiasis.. PubMed. 28(1). 21–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026